SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-23-024692
Filing Date
2023-05-15
Accepted
2023-05-15 16:06:02
Documents
64
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q brhc20052917_10q.htm   iXBRL 10-Q 836000
2 EXHIBIT 31.1 brhc20052917_ex31-1.htm EX-31.1 12484
3 EXHIBIT 31.2 brhc20052917_ex31-2.htm EX-31.2 12316
4 EXHIBIT 32.1 brhc20052917_ex32-1.htm EX-32.1 5130
5 EXHIBIT 32.2 brhc20052917_ex32-2.htm EX-32.2 4996
11 image01.jpg GRAPHIC 77870
12 image02.jpg GRAPHIC 76958
13 image03.jpg GRAPHIC 33622
  Complete submission text file 0001140361-23-024692.txt   5119870

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20230331.xsd EX-101.SCH 36891
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pdsb-20230331_cal.xml EX-101.CAL 39461
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pdsb-20230331_def.xml EX-101.DEF 162657
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20230331_lab.xml EX-101.LAB 537489
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20230331_pre.xml EX-101.PRE 306174
58 EXTRACTED XBRL INSTANCE DOCUMENT brhc20052917_10q_htm.xml XML 588729
Mailing Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 23922058
SIC: 2834 Pharmaceutical Preparations